2020
DOI: 10.26434/chemrxiv.11860077.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds

Abstract: <div>The recently emerged 2019 Novel Coronavirus (SARS-CoV-2) and associated COVID-19 disease cause serious or even fatal respiratory tract infection and yet no FDA-approved therapeutics or effective treatment is currently available to effectively combat the outbreak. This urgent situation is pressing the world to respond with the development of novel vaccine or a small molecule therapeutics for SARS-CoV-2. Along these efforts, the structure of SARS-CoV-2 main protease (Mpro) has been rapidly resolved an… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 21 publications
(26 reference statements)
0
1
0
Order By: Relevance
“…To fight against COVID-19 and promote the prevention and control of the epidemic, researchers have recently made efforts in various aspects; their research involves epidemiological research 5,6,7 , diagnostic methods of the novel coronavirus 8,9,10,11 , clinical characteristics of the disease 12,13,14,15,16 , characteristics of disease transmission 17,18,19 , development of candidate therapies 20,21,22 , the identification of animal hosts 23,24,25,26 , etc. However, there has been no research conducted on the public's attention to COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…To fight against COVID-19 and promote the prevention and control of the epidemic, researchers have recently made efforts in various aspects; their research involves epidemiological research 5,6,7 , diagnostic methods of the novel coronavirus 8,9,10,11 , clinical characteristics of the disease 12,13,14,15,16 , characteristics of disease transmission 17,18,19 , development of candidate therapies 20,21,22 , the identification of animal hosts 23,24,25,26 , etc. However, there has been no research conducted on the public's attention to COVID-19.…”
Section: Introductionmentioning
confidence: 99%